Sinovac Biotech Directors Reject Alternative Liquidity’s Lowball Tender Offer
China-based Sinovac Biotech Ltd. (NASDAQ: SVA) announced that its Board of Directors has unanimously determined...
Abbott to Acquire Insulin Management Firm Bigfoot Biomedical
Healthcare giant Abbott (NYSE: ABT) has announced an agreement to purchase Bigfoot Biomedical, a company...
Taizhou Port Designated as Drug Import Port by NMPA and General Administration of Customs
The National Medical Products Administration (NMPA) and the General Administration of Customs have released a...
Sandoz Reports H1 2023 Financials with 8% YOY Growth, Separation from Novartis Looms
Switzerland-based Sandoz (SWX: SDZ) has published its financial statements for the first half of 2023,...
Li Li Appointed as New Director of NMPA
The State Council has released an announcement regarding appointments and dismissals within the government. Among...
NHSA Mandates National Standards for Medical Consumables in Basic Medical Insurance
The National Healthcare Security Administration (NHSA) has released a notification with a focus on enhancing...
Bristol-Myers Squibb Acquires Rights to Zenas BioPharma’s Obexelimab for Autoimmune Diseases
US pharmaceutical major Bristol-Myers Squibb (BMS; NYSE: BMY) has entered into a licensing and cooperation...
Neurophth Biotechnology’s NFS-05 Gene Therapy Gets Australian Clinical Trial Approval for ADOA
China-based gene therapy specialist Neurophth Biotechnology Ltd has announced that it has received clinical trial...
MGI Tech Partners with Eight Companies to Expand G99-Based Sequencing Applications
China-based MGI Tech, a subsidiary of BGI Group (SHE: 300676), has entered into cooperation agreements...
Harbin Gloria Pharmaceuticals’ Zimberelimab Receives NMPA Approval for Cervical Cancer Treatment
China-based Harbin Gloria Pharmaceuticals Co., Ltd (SHE: 002437) has announced that it has received market...
Janssen Appoints Cherry Huang as President of Xi’an Janssen in China Management Shake-Up
The Janssen unit of Johnson & Johnson (J&J; NYSE: JNJ) has announced a significant management...
Seagen and Genmab Announce Positive Phase III Results for Tivdak in Cervical Cancer
Seagen (NASDAQ: SGEN), currently in the process of being acquired by Pfizer (NYSE: PFE), and...
SinoMab BioScience’s Suciraslimab Files for Market Approval in China for Rheumatoid Arthritis
Hong Kong-based biotech company SinoMab BioScience Ltd (HKG: 3681) has announced that a market approval...
Weight-Loss Drug Demand Pushes Novo Nordisk to Peak European Market Capitalization
Denmark-headquartered pharmaceutical giant Novo Nordisk (NYSE: NVO) achieved a significant milestone last week when it...
Janssen Sues Distributors Over Counterfeit Antiretroviral Therapies in the US
Johnson & Johnson’s (J&J; NYSE: JNJ) subsidiary, Janssen, filed a lawsuit last week against pharmaceutical...
Columbia University Study Weighs Cost-Effectiveness of Weight-Loss Treatments for Adolescents
Researchers at US Columbia University have published the results of a study estimating the cost-effectiveness...
Shanghai Pharmaceuticals Executives Under Investigation for Serious Disciplinary Violations
China-based pharmaceutical distribution giant Shanghai Pharmaceuticals (SPH; HKG: 2607; SHA: 601607) has disclosed that several...
BDgene Technology Announces Clinical Milestone for CRISPR-Cas9 Gene Therapy in HSK
Gene therapy specialist Shanghai BDgene Technology Co., Ltd has announced the conclusion of three clinical...
Sanofi Announces Management Restructuring with New Leadership Roles in China
French pharmaceutical giant Sanofi (NASDAQ: SNY) has announced a significant restructuring of its management structure...
ImmuneOnco Biopharmaceuticals Begins Trading on HKEX with Successful IPO
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd (HKG: 1541) marked its debut on the Hong Kong Stock...